GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » COGS-to-Revenue

Holdco Nuvo Group DG (Holdco Nuvo Group DG) COGS-to-Revenue : 1.09 (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG COGS-to-Revenue?

Holdco Nuvo Group DG's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.19 Mil. Its Revenue for the six months ended in Dec. 2023 was $0.18 Mil.

Holdco Nuvo Group DG's COGS to Revenue for the six months ended in Dec. 2023 was 1.09.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Holdco Nuvo Group DG's Gross Margin % for the six months ended in Dec. 2023 was -8.52%.

Holdco Nuvo Group DG COGS-to-Revenue Historical Data

The historical data trend for Holdco Nuvo Group DG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG COGS-to-Revenue Chart

Holdco Nuvo Group DG Annual Data
Trend Dec21 Dec22 Dec23
COGS-to-Revenue
- - 1.09

Holdco Nuvo Group DG Semi-Annual Data
Dec21 Dec22 Dec23
COGS-to-Revenue - - 1.09

Holdco Nuvo Group DG COGS-to-Revenue Calculation

Holdco Nuvo Group DG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.191 / 0.176
=1.09

Holdco Nuvo Group DG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.191 / 0.176
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Holdco Nuvo Group DG  (NAS:NUVO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Holdco Nuvo Group DG's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.191 / 0.176
=-8.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Holdco Nuvo Group DG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Holdco Nuvo Group DG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » COGS-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155
Website
https://www.nuvocares.com
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines

From GuruFocus

Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company's Commitment to Transforming Prenatal Care

By Marketwired • 05-09-2024